Abstract
An understanding of the cellular physiology of cardiac myocytes (MCs) and non-myocytes (NMCs) may help to explain the mechanisms underlying cardiac hypertrophy. Despite numerous studies using MC/NMC co-culture systems, it is difficult to precisely evaluate the influence of each cell type because of the inherent cellular heterogeneity of such a system. Here we developed a co-culture system using Wistar rat neonatal MCs and NMCs isolated by discontinuous Percoll gradient and adhesion separation methods and cultured on either side of insert well membranes. Co-culture of MCs and NMCs resulted in significant increases in [3H]-leucine incorporation by MCs, in the amount of protein synthesized by MCs, and in the secretion of natriuretic peptides, while the addition of MCs to NMC cultures significantly reduced [3H]-thymidine incorporation by NMCs. Interestingly, the percentage of the brain natriuretic peptide (BNP) component of total natriuretic peptide secreted (atrial natriuretic peptide+BNP) increased as the number of NMCs placed in the MC/NMC co-culture system increased. However, MCs did not affect production of angiotensin II (Ang II) by NMCs or secretion of endothelin-1 and transforming growth factor-β1 into the MC/NMC co-culture system. This finding was supported by the anti-hypertrophic and anti-fibrotic actions of RNH6270, an active form of olmesartan, on MCs in the MC/NMC co-culture system and on NMCs that may synthesize Ang II in the heart. The present data indicate that cardiac fibrosis may not only facilitate MC hypertrophy (possibly through the local angiotensin system) but may also change particular pathophysiological properties of MCs, such as the secretory pattern of natriuretic peptides.
Similar content being viewed by others
Article PDF
References
Flanders KC, Holder MG, Winokur TS : Autoinduction of mRNA and protein expression for transforming growth factor-βs in cultured cardiac cells. J Mol Cell Cardiol 1995; 27: 805–812.
Harada M, Itoh H, Nakagawa O, et al: Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997; 96: 3737–3744.
Harada M, Saito Y, Kuwahara K, et al: Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol 1998; 31 ( Suppl 1): S357–S359.
Ikeda K, Tojo K, Tokudome G, et al: Possible involvement of endothelin-1 in cardioprotective effects of benidipine. Hypertens Res 2000; 23: 491–496.
Ikeda K, Tojo K, Oki Y, Nakao K : Urocortin has cell-proliferative effects on cardiac non-myocytes. Life Sci 2002; 71: 1929–1938.
Ikeda K, Tojo K, Otsubo C, et al: 5-Hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochem Biophys Res Commun 2005; 328: 522–525.
Ikeda K, Tojo K, Otsubo C, et al: Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes. Peptides 2005; 26: 2473–2481.
Horio T, Tokudome T, Maki T, et al: Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts. Endocrinology 2003; 144: 2279–2284.
Camelliti P, Camelliti, Kohl P : Microstructured cocultures of cardiac myocytes and fibroblasts: a two dimensional in-vitro model of cardiac tissue. Microsc Microanal 2005; 11: 249–259.
Brandt SP : Microgenomics: gene expression analysis at the tissue-specific and single-cell levels. J Exp Bot 2005; 56: 495–505.
Diks SH, Peppelenbosch MP : Single cell proteomics for personalised medicine. Trends Mol Med 2004; 10: 574–577.
Zak R : Cell proliferation during cardiac growth. Am J Cardiol 1971; 31: 211–219.
Mizuno M, Sada T, Ikeda M, et al: Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol 1995; 285: 181–188.
Smith PK, Krohn RI, Hermanson GT, et al: Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76–85.
Cameron VA, Rademaker MT, Ellmers LJ, Espiner EA, Nicholls MG, Richards AM : Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology 2000; 141: 4690–4697.
Tsuruda T, Boerrigter G, Huntley B, et al: Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 2002; 91: 1127–1134.
Miyata N, Park F, Li XF, Cowley AW Jr : Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 1999; 277: F437–F446.
Tsubou Y, Kobayashi N, Mita S, Yoshida K, Matsuoka H : Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-β1 gene in rats. Eur J Pharmacol 2002; 457: 85–93.
Fang X, Song Y, Zemans R, Hirsch J, Matthay MA : Fluid transport across cultured rat alveolar epithelial cells: a novel in vitro system. Am J Physiol 2004; 287: L104–L110.
Jans SW, de Jong YF, Reutelingsperger CP, van der Vusse GJ, van Bilsen M : Differential expression and localization of annexin V in cardiac myocytes during growth and hypertrophy. Mol Cell Biochem 1998: 178: 229–236.
Pandey KN : Biology of natriuretic peptides and their receptors. Peptides 2005; 26: 901–932.
Smith MW, Espiner EA, Yandle TG, Charles CJ, Richards AM : Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol 2000; 167: 239–246.
Fielitz J, Dendorter A, Pregla R, et al: Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation 2002; 105: 286–289.
Danser AHJ, Saris JJ : Prorenin uptake in the heart: a prerequisite for local angiotensin generation? J Moll Cell Cardiol 2002; 34: 1463–1472.
Wollert KC, Drexler H : The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999; 43: 838–849.
Schwocho LR, Masonson HN : Pharmacokinetics of CS-866, a new angiotensin II receptor blocker, in healthy subjects. J Clin Pharmacol 2001; 41: 515–527.
Laeis P, Püchler K, Kirch W : The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. J Hypertens 2001; 19 ( Suppl): S21–S32.
Jia N, Okamoto H, Shimizu T, et al: A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin β1 expression. Hypertens Res 2003; 26: 737–742.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, K., Tojo, K., Udagawa, T. et al. Cellular Physiology of Rat Cardiac Myocytes in Cardiac Fibrosis: In Vitro Simulation Using the Cardiac Myocyte/Cardiac Non-Myocyte Co-Culture System. Hypertens Res 31, 693–706 (2008). https://doi.org/10.1291/hypres.31.693
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.693
Keywords
This article is cited by
-
Atrophied cardiomyocytes and their potential for rescue and recovery of ventricular function
Heart Failure Reviews (2016)